Home > Archive > Hepatitis disease > September 2006 > India the new hub for clinical trials





You are viewing an archived Text-only version of the thread. To view this thread in it's original format and/or if you want to reply to this thread please [click here]

Author India the new hub for clinical trials
abhishekg4u@gmail.com

2006-09-03, 4:26 pm

India is becoming the new hub of clinical trials for hepatitis and
other drugs. I recently have joined a contract research organization in
India called Progressive Life Sciences
(http://www.progressivelifesciences.com/) which provides clinical trial
management, data management, site managment, clinical trial monitoring,
medical consulting, regulatory consulting, medical writing, in India.

They cater to the ever growing Clinical Research outsourcing market.
This market in India is projected to grow to 1.5 billion USD in the
next years. Heptatis form a major portion of the new drugs undergoing
trials, along with Diabetes, and Oncology.

Abhishek
Progressive Life Sciences
http://www.progressivelifescieces.com

Copyright 2003 - 2008 pahealthsystems.com